Drug Information

Drug General Information
Drug ID
D0Z7QZ
Former ID
DNC007406
Drug Name
N-(thiazol-2-yl)benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528805]
Formula
C10H8N2OS
Canonical SMILES
C1=CC=C(C=C1)C(=O)NC2=NC=CS2
InChI
1S/C10H8N2OS/c13-9(8-4-2-1-3-5-8)12-10-11-6-7-14-10/h1-7H,(H,11,12,13)
InChIKey
SCQBDADQAVXTMZ-UHFFFAOYSA-N
PubChem Compound ID
569547
Target and Pathway
Target(s) mRNA of human 5-lipoxygenase Target Info Inhibitor [528805]
BioCyc Pathway Aspirin-triggered lipoxin biosynthesis
Resolvin D biosynthesis
Leukotriene biosynthesis
Lipoxin biosynthesis
Aspirin triggered resolvin D biosynthesis
Aspirin triggered resolvin E biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Serotonergic synapse
Ovarian steroidogenesis
Toxoplasmosis
NetPath Pathway IL4 Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Arachidonic acid metabolism
Eicosanoid Synthesis
Selenium Micronutrient Network
References
Ref 528805J Med Chem. 2007 May 31;50(11):2640-6. Epub 2007 Apr 27.Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
Ref 528805J Med Chem. 2007 May 31;50(11):2640-6. Epub 2007 Apr 27.Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.